Full-Time

Vice President

Investment Banking, Biotech

Updated on 9/4/2026

Deadline 9/11/26
Wells Fargo

Wells Fargo

10,001+ employees

Nationwide banking and financial services

Compensation Overview

$185k - $300k/yr

+ Incentive opportunities

San Francisco, CA, USA + 2 more

More locations: Charlotte, NC, USA | New York, NY, USA

In Person

The position may require travel up to 50% of the time.

Category
Finance & Banking (1)
Required Skills
Microsoft Office
Word/Pages/Docs
Risk Management
Mergers & Acquisitions (M&A)
Investment Banking
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Wells Fargo

See people who can refer or advise you

Requirements
  • At least 5 years of Investment Banking experience, or equivalent demonstrated through work experience, training, military experience, or education.
  • Registration for the Securities Industry Essentials exam must be completed within 90 days of hire if it is not transferable upon hire; FINRA-recognized equivalents are accepted.
  • Registration for FINRA Series 63 or Series 66 must be completed within 90 days of hire if it is not transferable upon hire; FINRA-recognized equivalents are accepted.
  • Registration for FINRA Series 79 must be completed within 90 days of hire if it is not transferable upon hire; FINRA-recognized equivalents are accepted.
  • Successful completion of FINRA background screening and compliance with ongoing regulatory obligations are required.
  • Employees affected by outside-activity or personal-investing compliance policies must provide information to the Wells Fargo Personal Account Dealing Team and comply with applicable policies.
Responsibilities
  • Lead complex initiatives and independently manage client relationships, including origination, structuring, and execution of Corporate and Investment Banking products and services.
  • Drive strategic planning and deliver comprehensive solutions in mergers and acquisitions across public and private clients and in capital markets.
  • Analyze and resolve multifaceted business and operational challenges, making decisions that influence cross-functional teams and advance new initiatives.
  • Apply deep knowledge of products, markets, and clients while ensuring compliance and precision in execution.
  • Manage multiple projects in a fast-paced environment while mentoring peers and fostering collaboration.
Desired Qualifications
  • At least 5 years of Healthcare Investment Banking experience.
  • Experience in Biotech.
  • Strong track record of originating and executing mergers and acquisitions and capital markets transactions.
  • Ability to lead and coach junior staff.
  • Ability to communicate effectively, in both written and verbal formats, with senior executive-level leaders and clients.
  • Persuasive communication skills with comfort speaking with business stakeholders and clients.
  • High proficiency in Microsoft Office applications, particularly Excel, Word, and PowerPoint.
  • Ability to make timely and independent judgment decisions in a fast-paced and results-driven environment.
  • Knowledge and understanding of business development, including business vision, strategies, and goals.

Wells Fargo provides banking, investment, and payment services to individuals, businesses, and institutions. Its products include checking and savings accounts, loans, credit cards, wealth management, and payments, accessible through branches, online and mobile platforms, and full payment rails. The company combines a wide national footprint with a long history and a business model that integrates banking, investment, and payments, supported by a large network of branches and ATMs. Its goal is to help customers manage money, grow wealth, and move funds safely and reliably.

Company Size

10,001+

Company Stage

IPO

Headquarters

San Francisco, California

Founded

1851

Get referred to Wells Fargo

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 2Q26 revenue rose 9% to $22.6 billion, led by noninterest income.
  • 2Q26 wealth revenue grew 13% as advisory fees rose with markets.
  • March 2026 Fed ended its final fake-accounts enforcement action.

What critics are saying

  • July 2026 headcount fell to 197,000 after 24 straight quarterly declines.
  • Legacy misconduct still drives active class actions through 2026.
  • Another controls failure would resurrect federal oversight and kill the turnaround.

What makes Wells Fargo unique

  • March 2026 Fargo passed 1 billion interactions and 33 million mobile users.
  • 2Q26 wealth assets reached $2.69 trillion after a five-year revamp.
  • 2026 adviser recruiting now attracts independent advisers using Wells Fargo's platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Parental Leave

Disability Insurance

Life Insurance

Tuition Reimbursement

Commuter Benefits

Adoption Assistance

Company News

Kalkine Media
Sep 4th, 2026
IDEX extends $800M credit facility maturity to 2031

IDEX Corporation has amended its revolving credit facility, extending the maturity date to September 3, 2031, from the previous November 1, 2027. The facility maintains its $800 million principal amount. The agreement, finalised on September 3, 2026, allows for up to $100 million in letters of credit and $50 million in same-day swingline loans. IDEX may request additional lending commitments, capped at a $400 million increase. Bank of America serves as administrative agent, with JPMorgan Chase Bank, PNC Bank, and Wells Fargo Bank as co-syndication agents. The proceeds will fund working capital and general corporate purposes, including refinancing existing debt. The agreement includes standard covenants for senior unsecured credit facilities, featuring a quarterly-tested leverage ratio and restrictions on liens and mergers. Voluntary prepayments are permitted without penalty.

Yahoo Finance
Aug 31st, 2026
Vertex Pharmaceuticals shows promise while GE HealthCare and Wells Fargo face challenges

Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.

Yahoo Finance
Aug 31st, 2026
Wells Fargo ramps up adviser recruitment after five-year wealth overhaul

Wells Fargo is ramping up recruitment of financial advisers following a five-year overhaul of its wealth management division, Bloomberg reported. The bank is focusing on independent advisers who use its platform rather than salaried employees. Gianluca Palermo joined from Bank of America earlier this year, bringing $1.8 billion in client assets. James Taylor moved his team and nearly $6 billion in client assets from Morgan Stanley in May. The initiative is part of restructuring led by Barry Sommers, who has overseen wealth management since 2020. The bank's reputation had suffered from scandals that prompted thousands of advisers to depart. A Federal Reserve asset growth restriction, imposed after the fake accounts scandal, was lifted last year.

Minichart
Aug 29th, 2026
Choice Hotels secures $500M term loan with 2029 maturity and acquisition flexibility

Choice Hotels International has entered into a senior unsecured credit agreement for a $500 million term loan, maturing on 28 August 2029, with an optional one-year extension. Wells Fargo Securities, BofA Securities, Truist Securities, and PNC Capital Markets arranged the facility. The company announced the agreement on 28 August 2026. Interest on the loan is set at either SOFR plus 1.25% or a base rate plus 0.25%. The proceeds will fund general corporate purposes, including working capital and debt repayment. The agreement includes a maximum consolidated leverage ratio of 4.5 to 1.0, which can increase to 5.5 to 1.0 for acquisitions exceeding $750 million. The credit agreement also restricts additional debt, certain investments, and mergers or asset sales.

Business Wire
Aug 27th, 2026
Socure Announces Strategic Growth Investment at $5.2B Valuation and Acquires Agentic Operations Platform Fravity

Socure, a leading trust infrastructure for global identity and risk intelligence, today announced a strategic growth investment that values the company at $5...